10:06 PM
Sep 11, 2018
 |  BC Extra  |  Company News

Takeda to move U.S. headquarters to Boston

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will move its U.S. headquarters from Deerfield, Ill., to a to-be-determined site in the greater Boston area after its planned acquisition of Shire plc (LSE:SHP; NASDAQ:SHPG) closes next half.

Takeda spokesperson Julia Ellwanger told BioCentury the Japanese pharma decided to close Deerfield to simplify the pharma's existing U.S. operations and set up...

Read the full 264 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >